These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2166103)

  • 1. Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis.
    Glass AR; Cerletty JM; Elliott W; Lemann J; Gray RW; Eil C
    J Endocrinol Invest; 1990 May; 13(5):407-13. PubMed ID: 2166103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia.
    Adams JS; Sharma OP; Diz MM; Endres DB
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1090-5. PubMed ID: 2318934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients.
    Glass AR; Eil C
    J Clin Endocrinol Metab; 1988 May; 66(5):934-8. PubMed ID: 3360901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of sarcoidosis-associated hypercalcemia with ketoconazole.
    Bia MJ; Insogna K
    Am J Kidney Dis; 1991 Dec; 18(6):702-5. PubMed ID: 1962657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D.
    Glass AR; Eil C
    J Clin Endocrinol Metab; 1986 Sep; 63(3):766-9. PubMed ID: 3755445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia.
    Saggese G; Bertelloni S; Baroncelli GI; Di Nero G
    Am J Dis Child; 1993 Mar; 147(3):270-3. PubMed ID: 8438806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypercalcemia in sarcoidosis--case report, prevalence, pathophysiology and therapeutic options].
    Ackermann D
    Ther Umsch; 2007 May; 64(5):281-6. PubMed ID: 17685088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
    Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of sarcoidosis treated with cellulose sodium phosphate.
    Dwarakanathan A; Ryan WG
    Bone Miner; 1987 Jul; 2(4):333-6. PubMed ID: 2851338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease.
    Maesaka JK; Batuman V; Pablo NC; Shakamuri S
    Arch Intern Med; 1982 Jun; 142(6):1206-7. PubMed ID: 6896430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol-mediated hypercalcemia: causes and course in 101 patients.
    Donovan PJ; Sundac L; Pretorius CJ; d'Emden MC; McLeod DS
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4023-9. PubMed ID: 23979953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexisting primary hyperparathyroidism and sarcoidosis in a patient with severe hypercalcemia.
    Yoshida T; Iwasaki Y; Kagawa T; Sasaoka A; Horino T; Morita T; Hashimoto K
    Endocr J; 2008 May; 55(2):391-5. PubMed ID: 18385529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced production rate of 1,25-dihydroxyvitamin D in sarcoidosis.
    Insogna KL; Dreyer BE; Mitnick M; Ellison AF; Broadus AE
    J Clin Endocrinol Metab; 1988 Jan; 66(1):72-5. PubMed ID: 3335611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
    Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
    J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis.
    Adams JS; Gacad MA; Anders A; Endres DB; Sharma OP
    Sarcoidosis; 1986 Mar; 3(1):1-6. PubMed ID: 3033783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of hypercalcemia in a patient with Addison's disease.
    Muls E; Bouillon R; Boelaert J; Lamberigts G; Van Imschoot S; Daneels R; De Moor P
    Calcif Tissue Int; 1982; 34(6):523-6. PubMed ID: 6819071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid effect of prednisolone on serum 1,25-dihydroxycholecalciferol levels in hypercalcemic sarcoidosis.
    Nordal KP; Dahl E; Halse J; Aksnes L; Aarskog D
    Acta Med Scand; 1985; 218(5):519-23. PubMed ID: 3841460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
    Jacobs TP; Gordon AC; Silverberg SJ; Shane E; Reich L; Clemens TL; Gundberg CM
    Am J Med; 1987 Feb; 82(2A):42-50. PubMed ID: 3030098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.